Tag: CRSM

Stock, Options Gainers, & More

Reviewing Winning Options Plays: 

We kicked off the fresh trading week yesterday with a pair of options ideas and we typically met with some pretty solid intraday gain chances for ourselves and our readers.

We were after the TSLA Weekly $645-650 Calls and the HAS Weekly $94.50-96 Calls, and they both exhibited the activity we were looking for on the day. With the exception of one set in our designated ranges, the HAS $94.50’s, the rest of our targets produced excellent results.

Here were the daily ranges and total gains on the table for yesterday’s ideas:

TSLA Weekly $645-650 Calls 
$645: 23.80-35.80 (+50%)
$647.50: 22.65-34.15 (+51%)
$650: 21.15-32.50 (+54%)
______

HAS Weekly $94.50-96 Calls
$95: 2.90-9.10 (+214%)
$95.50: 2.04-9.30 (+356%)
$96: 3.39-8.03 (+137%)
______

Fresh Options Ideas:
UPS Weekly $210-205 Puts
GE Weekly $12.50-13 Calls
RTX Weekly $86.50-87.50 Calls 

OTC Recaps:

Signature Devices Inc. SDVI – We’ve been tracking SDVI all month long, with mentions on the 1st of July, as well as another last week, and a tag in yesterday’s report. Over that time span, this super-subpenny play has made a fairly decent run and approached subpenny territory.

Subsequent to our initial alert on the 1st, the stock has made a 200% run from .0003-.0009. We’ll continue to watch for the stock’s breach into double-zero figures in the days ahead.
_____

CyberLux Corp. CYBL – Speaking of plays we’ve been on top of for the month of July, CYBL has appeared many times since the end of last month, in our report on June 28th. It would see a low of .0045 and after four solid weeks of incremental gains, the stock hit .0167 to start the week off yesterday. That marks a move of 271%

Extended Watchlist:
EYEG, OBSV, OGEN, METX, PBYA, RSHN, CRSM, TXTM, TMXN, BTSC, PLYZ

GS, PEP Options Review, Fresh Ideas & More

GS, PEP Options Breakout:

With the earnings drought just days away from finally ending, we still have been managing to seek out winning plays. As we’ve said, next week begins a torrential outpouring of quarterly reporters on the order of dozens, if not hundreds per day!

We got back on the track of options perfection yesterday, with both of our fresh ideas in our premarket report yielding stellar intraday chances to profit. We had selected the GS Weekly $380-385 Calls and the PEP Weekly $149-152.50 Calls following Goldman Sachs and Pepsi’s earnings releases.

Despite an up-and-down sort of a session for the markets at large, we witnessed some serious multibag moves from every single contract we slated for observation. Here are the total possible gains that traders could have logged on the strength of those ideas:

GS Weekly $380-385 Calls
$380: 1.64-4.69 (+186%)
$382.50: 1.19-3.68 (+209%)
$385: .85-2.89 (+240%)
_____

PEP Weekly $149-152.50 Calls 
$149: 2.20-4.95 (+125%)
$150: 1.50-4.00 (+167%)
$152.50: .43-1.73 (+302%)

Fresh Options Ideas:
SPY 07/14 $436-437 Calls*
C Weekly $69-70 Calls

*Please be aware that these SPY Calls will expire at the end of the trading day. Trading options on the day of their expiration is a high-risk/high-reward proposition that should only be undertaken by experienced traders!

Extended Watchlist:
OXBR, XELA, JZXN, MINM, CTIB, DTSS, RMRK, CYBL, BLEG, MSAV, BTDG, CRSM

Closing Out Another Excellent Trading Week

Instant Payoff Earnings Plays:

Out of the trio of fresh options ideas that we included in yesterday morning’s premarket report, two really stood out as the clear winners. We had signaled plays in the AT&T and Las Vegas Sands options chains on the heels of each company’s quarterly earnings reports.

Our specific target ranges were the T Weekly $27-28 Calls and the LVS Weekly $47-48 Calls, and the potential gains on the day were considerable.

T Weekly $27-28 Calls
$27: .80-1.50 (+88%)
$27.50: .32-1.02 (+219%)
$28: .15-.57 (+280%)
_____

LVS Weekly $47-48 Calls 
$48: 1.53-3.15 (+106%)
$49: .88-2.36 (+168%)

Fresh Options Ideas:

X Weekly $8.50 Calls
CLF Weekly $8.50-9 Calls
COF Weekly $78-80 Calls

Extended Watchlist:
DPWW, CRSM, BCHG, BTGN, BLFE, FRMA